Literature DB >> 17472844

Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan.

Jinn-Yuh Guh1, Hung-Chun Chen, Jung-Fa Tsai, Lea-Yea Chuang.   

Abstract

BACKGROUND: Taiwan has the greatest incidence rate of end-stage renal disease in the world. Several cases of Chinese herb nephropathy were reported in Taiwan. Therefore, we studied the association between herbal therapy and chronic kidney disease (CKD) in Taiwan. STUDY
DESIGN: Cross-sectional survey. SETTING & PARTICIPANTS: 1,740 adults in the Nutrition and Health Survey in Taiwan (1993 to 1996). PREDICTOR: Herbal and analgesic therapy. OUTCOMES & MEASUREMENTS: CKD after adjustment for potential confounding variables.
RESULTS: Among medication users, prevalences of herbal therapy and analgesic use were 21.6% and 13.2%, respectively. The prevalence of CKD was 9.9%. Participants with CKD were older and had more analgesic use, diabetes, hypertension, and cardiovascular disease. Analgesic use was associated independently and positively with CKD (odds ratio, 2.2; 95% confidence interval, 1.4 to 3.5; P = 0.003) and CKD stage (odds ratio, 2.3; 95% confidence interval, 1.4 to 3.6; P = 0.003). Conversely, herbal therapy was associated independently and positively with CKD (odds ratio, 1.39; 95% confidence interval, 1.2 to 1.7; P = 0.002) and CKD stage (odds ratio, 1.38; 95% confidence interval, 1.1 to 1.7; P = 0.004) only in participants who did not use analgesics. LIMITATIONS: Because this was a cross-sectional study, cause and effect could not be ascertained.
CONCLUSIONS: Herbal therapy was associated with CKD in adults in Taiwan who did not use analgesics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472844     DOI: 10.1053/j.ajkd.2007.02.259

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  13 in total

1.  Association of prescribed Chinese herbal medicine use with risk of end-stage renal disease in patients with chronic kidney disease.

Authors:  Ming-Yen Lin; Yi-Wen Chiu; Jung-San Chang; Hung-Lung Lin; Charles Tzu-Chi Lee; Guei-Fen Chiu; Mei-Chuan Kuo; Ming-Tsang Wu; Hung-Chun Chen; Shang-Jyh Hwang
Journal:  Kidney Int       Date:  2015-08-05       Impact factor: 10.612

Review 2.  Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

Authors:  Joanne Chiu; Thomas Yau; Richard J Epstein
Journal:  Support Care Cancer       Date:  2008-11-14       Impact factor: 3.603

3.  High prevalence and associated risk factors for impaired renal function and urinary abnormalities in a rural adult population from southern China.

Authors:  Qinghua Liu; Zhibin Li; Hui Wang; Xiaochao Chen; Xiuqing Dong; Haiping Mao; Jiaqing Tan; Ning Luo; Richard J Johnson; Weiqing Chen; Xueqing Yu; Wei Chen
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

4.  Evaluating weight of evidence in the mystery of Balkan endemic nephropathy.

Authors:  Travis Bui-Klimke; Felicia Wu
Journal:  Risk Anal       Date:  2014-06-20       Impact factor: 4.000

Review 5.  Chronic kidney disease in low-income to middle-income countries: the case for increased screening.

Authors:  Cindy George; Amelie Mogueo; Ikechi Okpechi; Justin B Echouffo-Tcheugui; Andre Pascal Kengne
Journal:  BMJ Glob Health       Date:  2017-05-29

6.  Are non-cardiac surgeries safe for dialysis patients? - A population-based retrospective cohort study.

Authors:  Yih-Giun Cherng; Chien-Chang Liao; Tso-Hsiao Chen; Duan Xiao; Chih-Hsiung Wu; Ta-Liang Chen
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

7.  Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003.

Authors:  Shu-Ching Hsieh; I-Hsin Lin; Wei-Lum Tseng; Chang-Hsing Lee; Jung-Der Wang
Journal:  Chin Med       Date:  2008-10-23       Impact factor: 5.455

8.  Prevalence of herbal and dietary supplement usage in Thai outpatients with chronic kidney disease: a cross-sectional survey.

Authors:  Mayuree Tangkiatkumjai; Helen Boardman; Kearkiat Praditpornsilpa; Dawn M Walker
Journal:  BMC Complement Altern Med       Date:  2013-07-01       Impact factor: 3.659

9.  End-stage renal disease in Taiwan: a case-control study.

Authors:  Su-Ying Tsai; Hung-Fu Tseng; Hsiu-Fen Tan; Yu-Shu Chien; Chia-Chu Chang
Journal:  J Epidemiol       Date:  2009-06-20       Impact factor: 3.211

10.  Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists.

Authors:  Hsiao-Yu Yang; Jung-Der Wang; Tsai-Chang Lo; Pau-Chung Chen
Journal:  J Epidemiol       Date:  2009-01-22       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.